Comment on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project". [Response to Letter].
作者信息
Spini Andrea, L'Abbate Luca, Ingrasciotta Ylenia, Pellegrini Giorgia, Carollo Massimo, Ientile Valentina, Leoni Olivia, Zanforlini Martina, Ancona Domenica, Stella Paolo, Cavazzana Anna, Scapin Angela, Lopes Sara, Belleudi Valeria, Trifirò Gianluca
机构信息
Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
出版信息
Clin Epidemiol. 2024 Jun 26;16:445-446. doi: 10.2147/CLEP.S482719. eCollection 2024.
Abstract
摘要
相似文献
1
Comment on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project". [Response to Letter].
Clin Epidemiol. 2024 Jun 26;16:445-446. doi: 10.2147/CLEP.S482719. eCollection 2024.
2
Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project.
Clin Epidemiol. 2024 Jun 4;16:395-407. doi: 10.2147/CLEP.S445120. eCollection 2024.
3
Comments on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project" [Letter].
Clin Epidemiol. 2024 Jun 14;16:431-432. doi: 10.2147/CLEP.S481983. eCollection 2024.
4
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project.
BioDrugs. 2021 Nov;35(6):749-764. doi: 10.1007/s40259-021-00498-3. Epub 2021 Oct 12.
5
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project.
Pharmacol Res. 2024 Feb;200:107074. doi: 10.1016/j.phrs.2024.107074. Epub 2024 Jan 15.
6
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy.
Clin Epidemiol. 2023 Mar 11;15:309-321. doi: 10.2147/CLEP.S383738. eCollection 2023.
7
Development and evaluation of an algorithm to identify users of Prolia(®) during the early postmarketing period using health insurance claims data.
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):993-8. doi: 10.1002/pds.3680. Epub 2014 Jul 23.
8
Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data".
Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):110-111. doi: 10.1002/pds.5376. Epub 2021 Oct 27.
9
Nationwide validation study of diagnostic algorithms for inflammatory bowel disease in Korean National Health Insurance Service database.
J Gastroenterol Hepatol. 2020 May;35(5):760-768. doi: 10.1111/jgh.14855. Epub 2019 Oct 27.
10
Development and validation of a predictive algorithm to identify adult asthmatics from medical services and pharmacy claims databases.
Health Serv Res. 2011 Jun;46(3):939-63. doi: 10.1111/j.1475-6773.2010.01235.x. Epub 2011 Jan 28.
本文引用的文献
1
Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project.
Clin Epidemiol. 2024 Jun 4;16:395-407. doi: 10.2147/CLEP.S445120. eCollection 2024.
Zotero 插件